1. Home
  2. RAPT vs KVHI Comparison

RAPT vs KVHI Comparison

Compare RAPT & KVHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • KVHI
  • Stock Information
  • Founded
  • RAPT 2015
  • KVHI 1978
  • Country
  • RAPT United States
  • KVHI United States
  • Employees
  • RAPT N/A
  • KVHI N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • KVHI Radio And Television Broadcasting And Communications Equipment
  • Sector
  • RAPT Health Care
  • KVHI Technology
  • Exchange
  • RAPT Nasdaq
  • KVHI Nasdaq
  • Market Cap
  • RAPT 122.9M
  • KVHI 101.5M
  • IPO Year
  • RAPT 2019
  • KVHI 1996
  • Fundamental
  • Price
  • RAPT $13.31
  • KVHI $5.28
  • Analyst Decision
  • RAPT Buy
  • KVHI
  • Analyst Count
  • RAPT 5
  • KVHI 0
  • Target Price
  • RAPT $36.75
  • KVHI N/A
  • AVG Volume (30 Days)
  • RAPT 133.4K
  • KVHI 28.4K
  • Earning Date
  • RAPT 08-07-2025
  • KVHI 08-04-2025
  • Dividend Yield
  • RAPT N/A
  • KVHI N/A
  • EPS Growth
  • RAPT N/A
  • KVHI N/A
  • EPS
  • RAPT N/A
  • KVHI N/A
  • Revenue
  • RAPT N/A
  • KVHI $109,975,000.00
  • Revenue This Year
  • RAPT N/A
  • KVHI $1.02
  • Revenue Next Year
  • RAPT N/A
  • KVHI $12.63
  • P/E Ratio
  • RAPT N/A
  • KVHI N/A
  • Revenue Growth
  • RAPT N/A
  • KVHI N/A
  • 52 Week Low
  • RAPT $5.67
  • KVHI $4.17
  • 52 Week High
  • RAPT $27.84
  • KVHI $6.16
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 69.39
  • KVHI 47.43
  • Support Level
  • RAPT $10.00
  • KVHI $5.25
  • Resistance Level
  • RAPT $14.09
  • KVHI $5.47
  • Average True Range (ATR)
  • RAPT 1.04
  • KVHI 0.16
  • MACD
  • RAPT 0.42
  • KVHI -0.01
  • Stochastic Oscillator
  • RAPT 87.32
  • KVHI 23.26

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

Share on Social Networks: